Old Web
English
Sign In
Acemap
>
Paper
>
Lenalidomide as second-line therapy for advanced hepatocellular carcinoma (HCC): biomarker exploration
Lenalidomide as second-line therapy for advanced hepatocellular carcinoma (HCC): biomarker exploration
2016
Y.-Y. Shao
B-B. Chen
Z.-Z. Lin
C.-H. Hsu
M.-J. Wang
A-L Cheng
C. Hsu
Keywords:
Lenalidomide
Second-line therapy
Hepatocellular carcinoma
Oncology
Medicine
Internal medicine
Biomarker (medicine)
Correction
Source
Cite
Save
Machine Reading By IdeaReader
0
References
1
Citations
NaN
KQI
[]